Chronic N(g)-nitro-L-arginine methyl ester-induced hypertension: Novel molecular adaptation to systolic load in absence of hypertrophy

Circulation

Volumn 101, Issue 4, 2000, Pages 423-429

  Bartunek, Jozef ^a,b   Weinberg, Ellen O ^a   Tajima, Minori ^a,c   Rohrbach, Susanne ^a   Katz, Sarah E ^a   Douglas, Pamela S ^a   Lorell, Beverly H ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CARDIOVASCULAR CENTER   (Belgium)

^c TOHOKU UNIVERSITY   (Japan)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Calcium; Hypertrophy; NG nitroarginine methyl ester; Nitric oxide; Remodeling

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA STENOSIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG INDUCED DISEASE; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0034141701     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.4.423     Document Type: Article

References (43)

1. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
2. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56-64.
3. Carg UC, Hassid A. Nitric oxide vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
4. Kolpakov V, Gordon D, Kulik TJ. Nitric-oxide generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res. 1995;76:305-309.
5. Ribeiro MO, Antunes E, de Nucci G, Lovisolos SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
6. Arnal JF, Warin L, Michel JP. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest. 1992;90:647-652.
7. Arnal JF, Amrani AI, Chatellier G, Menard J, Michel JP. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
8. Rhaleb NE, Yang XP, Scicli AG, Carretero OA. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension. 1994; 23(part 2):865-868.
9. Moreno H Jr, Metze K, Bento AC, Antunes E, Zatz R, de Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol. 1996;91:248-255.
10. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi H, Takeshita T. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest. 1997;99:278-287.
11. Hu L, Manning D Jr, Brands MW. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension. 1994;23:185-194.
12. Matsubara BB, Matsubara LS, Zornoff LA, Franco M, Janicki JS. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats. Basic Res Cardiol. 1998;93:173-181.
13. Baydoun AR, Mann GE. Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages. Biochem Biophys Res Commun. 1994;200:726-731.
14. Bogle RG, Moncada S, Pearson JD, Mann GE. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol. 1992;105:768-770.
15. Morgan DM. Polyamines, arginine, and nitric oxide. Biochem Soc Trans. 1994;22:879-883.
16. Kerwin JF Jr, Lancaster JR Jr, Feldman PF. Nitric oxide: a new paradigm for second messengers. J Med Chem. 1995;38:4343-4362.
17. Greenberg SS, Lancaster JR, Xie J, Sarphie TG, Zhao X, Hua L, Freeman T, Kapusta DR, Giles TD, Powers DR. Effects of NO synthase inhibitors, arginine-deficient diet and amiloride in pregnant rats. Am J Physiol. 1997;273:R1031-R1045.
18. Young M, Prenton M. Maternal and fetal plasma concentrations of amino acids during gestation and in retarded fetal growth. Br J Obstet Gynaecol. 1989;76:333-341.
19. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 1994;90:1410-1422.
20. Litwin SE, Katz SA, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function in rats with pressure overload hypertrophy: chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995;91:2642-2654.
21. Weinberg EO, Lee MA, Weigner M, Lindpaintner K, Bishop SP, Benedict CR, Ho KKL, Douglas PS, Chafizadeh E, Lorell BH. Angiotensin AT1 receptor inhibition: effects on hypertrophic remodeling and ACE mRNA expression in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 1997;95:1592-1600.
22. 2+ in myocytes from aortic-banded rats. Circulation. 1996;94:2915-2922.
23. Ito N, Bartunek J, Spitzer KW, Lorell BH. Effects of nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation. 1997;94:2303-2311.
24. 2+ exchanger function during early and late relaxation in ventricular myocytes. Am J Physiol. 1997;274:H2765-H2773.
25. Tajima M, Bartunek J, Weinberg EO, Lorell BH. Atrial natriuretic peptide has different effects on contractility and intracellular pH in normal and hypertrophied myocytes from pressure-overloaded hearts. Circulation. 1998;98:2760-2764.
26. Tajima M, Weinberg EO, Bartunek J, Jin H, Yan R, Paoni NF, Lorell BH. Treatment with growth hormone enhances contractile reserve and intracellular calcium in myocytes from rats with post-infarction heart failure. Circulation. 1999;99:127-134.
27. Bartunek J, Dempsey S, Weinberg EO, Ito N, Tajima M, Rohrbach S, Lorell BH. Chronic L-arginine treatment increases cardiac cyclic guanosine 5′-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve. J Am Coll Cardiol. 1998;32:528-535.
28. 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J Clin Invest. 1990;85:1206-1214.
29. Gaasch WH. Left ventricular radius to wall thickness ratio. Am J Cardiol. 1979;43:1189-1194.
30. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26: 195-202.
31. Pechanova O, Bernatova I, Pelouch V, Simko F. Protein remodeling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol. 1997;29:3365-3374.
32. Sladek T, Gerova M, Znojil V, Devat L. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res. 1996;45:335-338.
33. Delacretez E, Hayoz D, Osterheld MC, Genton CY, Brunner HR, Waeber B. Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension. 1994;23(part 2):967-970.
34. Keaney JF, Hare JM, Balligand JL, Loscalzo J, Smith TW, Colucci WS. Inhibition of nitric oxide synthase augments myocardial contractile responses to β-adrenergic stimulation. Am J Physiol. 1996;271: H2646-H2652.
35. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueshi K, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension. 1995;26(part 1):957-962.
36. Litwin SE, Raya TE, Anderson PG, Litwin CM, Breezier R, Goldman S. Induction of myocardial hypertrophy following coronary ligation in rats decreases left ventricular dilatation and improves systolic function. Circulation. 1991;84:1819-1827.
37. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
38. Shah AM, Spurgeon HA, Sollot SJ, Talo A, Lakatta EG. 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
39. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A. 1988;85:339-343.
40. 2+-ATPase and α-myosin heavy chain in rat hearts. J Clin Invest. 1997;100:1742-1749.
41. Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 1997; 100:2362-2370.
42. 2+-ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest. 1997;100:380-389.
43. 2+ flux, contractility and excitation-contraction coupling in hypertrophied rat ventricular myocytes. Am J Physiol. 1998;274: H1348-H1360.